MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/eci.13582

Медицинская библиотека · European journal of clinical investigation · 2021

COVID-19 and the impact of arterial hypertension-An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany).

El-Battrawy Ibrahim, Nuñez-Gil Ivan J, Abumayyaleh Mohammad, Estrada Vicente, Manuel Becerra-Muñoz Víctor, Uribarri Aitor, Fernández-Rozas Inmaculada, Feltes Gisela, Arroyo-Espliguero Ramón, Trabattoni Daniela, López-País Javier, Pepe Martino, Romero Rodolfo, Castro-Mejía Alex F, Cerrato Enrico, Capel Astrua Thamar, D'Ascenzo Fabrizio, Fabregat-Andres Oscar, Signes-Costa Jaime, Marín Francisco, Buonsenso Danilo, Bardají Alfredo, Jesús Tellez María, Fernández-Ortiz Antonio, Macaya Carlos, Akin Ibrahim

СтатьяПеревод в очереди

Аннотация

BACKGROUND

A systematic analysis of concomitant arterial hypertension in COVID-19 patients and the impact of angiotensin-converting-enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) have not been studied in a large multicentre cohort yet. We conducted a subanalysis from the international HOPE Registry (https://hopeprojectmd.com, NCT04334291) comparing COVID-19 in presence and absence of arterial hypertension.

MATERIALS AND

METHODS

Out of 5837 COVID-19 patients, 2850 (48.8%) patients had the diagnosis arterial hypertension. 1978/2813 (70.3%) patients were already treated with ACEI or ARBs. The clinical outcome of the present subanalysis included all-cause mortality over 40 days of follow-up.

RESULTS

Patients with arterial hypertension suffered significantly more from different complications including respiratory insufficiency (60.8% vs 39.5%), heart failure (9.9% vs 3.1%), acute kidney injury (25.3% vs 7.3%), pneumonia (90.6% vs 86%), sepsis (14.7% vs 7.5%), and bleeding events (3.6% vs 1.6%). The mortality rate was 29.6% in patients with concomitant arterial hypertension and 11.3% without arterial hypertension (P < .001). Invasive and non-invasive respiratory supports were significantly more required in presence of arterial hypertension as compared without it. In the multivariate cox regression analysis, while age≥65, benzodiazepine, antidepressant at admission, elevated LDH or creatinine, respiratory insufficiency and sepsis might be a positive independent predictors of mortality, antiviral drugs, interferon treatment, ACEI or ARBs at discharge or oral anticoagulation at discharge might be an independent negative predictor of the mortality.

CONCLUSIONS

The mortality rate and in-hospital complications might be increased in COVID-19 patients with a concomitant history of arterial hypertension. The history of ACEI or ARBs treatments does not seem to impact the outcome of these patients.

Для цитирования: El-Battrawy Ibrahim, Nuñez-Gil Ivan J, Abumayyaleh Mohammad, Estrada Vicente, Manuel Becerra-Muñoz Víctor, Uribarri Aitor, Fernández-Rozas Inmaculada, Feltes Gisela, Arroyo-Espliguero Ramón, Trabattoni Daniela, López-País Javier, Pepe Martino, Romero Rodolfo, Castro-Mejía Alex F, Cerrato Enrico, Capel Astrua Thamar, D'Ascenzo Fabrizio, Fabregat-Andres Oscar, Signes-Costa Jaime, Marín Francisco, Buonsenso Danilo, Bardají Alfredo, Jesús Tellez María, Fernández-Ortiz Antonio, Macaya Carlos, Akin Ibrahim. COVID-19 and the impact of arterial hypertension-An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany).. European journal of clinical investigation. 2021. DOI: 10.1111/eci.13582.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.